The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant
Details
Publication Year 1999-09,Volume 73,Issue #9,Page 7619-7626
Journal Title
JOURNAL OF VIROLOGY
Publication Type
Journal Article
Abstract
Many virus infections give rise to surprisingly limited T-cell responses directed to very few immunodominant determinants. We have been examining the cytotoxic T-lymphocyte (CTL) response to herpes simplex virus type 1 (HSV-1) infection. Previous studies have identified the glycoprotein E-derived peptide from residues 498 to 505 (gB(498-505)) as one of at least three determinants recognized by HSV-1-specific CTLs isolated from C57BL/6 mice. We had previously found that in vitro-derived CTLs directed to gB(498-505) show a characteristic pattern of T-cell receptor (TCR) usage, with 60% of gB(498-505)-specific CD8(+) T cells expressing BV10(+) TCR beta chains and a further 20% expressing BV8S1. In this report, we confirm that this TCR V-region bias is also reflected in the ex vivo response to HSV-1 infection. A high proportion of activated CD8(+) draining lymph node cells were found to express these dominant V regions, suggesting that a substantial number of in vivo responding T cells were directed to this one viral determinant. The use of an HSV-1 deletion mutant lacking the gB(498-505) determinant in combination with accurate intracellular gamma interferon staining allowed us to quantify the extent of gB-specific T-cell dominance. Together, these results suggested that between 70 and 90% of all CD8(+) HSV-1-specific T cells target gB(498-505). While deletion of this determinant resulted in an attenuated CD8(+) T-cell response, it also permitted the emergence of one or more previously unidentified cryptic specificities. Overall, HSV-1 infection of C57BL/6 mice results in am extremely focused pattern of CD8(+) T-cell selection in terms of target specificity and TCR expression.
Publisher
AMER SOC MICROBIOLOGY
Keywords
MAJOR HISTOCOMPATIBILITY COMPLEX; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CLASS-I; GLYCOPROTEIN-B; RECEPTOR GENES; BACTERIAL-INFECTION; ADENOVIRUS VECTORS; ALLELIC EXCLUSION; VIRAL-INFECTION; TCR-ALPHA
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 1999-09-01 12:00:00
An error has occurred. This application may no longer respond until reloaded. Reload 🗙